BeyondSpring Inc. Operating Lease, Liability, Noncurrent
BeyondSpring Inc. (BYSI) had Operating Lease, Liability, Noncurrent of $0 as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-03-25
- 2025-12-31: Operating Lease, Liability, Noncurrent $0.00.
- 2025-09-30: Operating Lease, Liability, Noncurrent $93.00K.
- 2025-06-30: Operating Lease, Liability, Noncurrent $170.00K.
- 2025-03-31: Operating Lease, Liability, Noncurrent $246.00K.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-25 | |
| 2025-09-30 | $93.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $170.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $246.00K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $307.00K 10-K · filed 2026-03-25 | |
| 2024-06-30 | $3.03M 6-K · filed 2024-08-29 | |
| 2023-12-31 | $589.00K 10-K · filed 2025-03-27 | $3.36M 6-K · filed 2024-08-29 |
| 2023-06-30 | $3.69M 6-K · filed 2024-02-02 | |
| 2022-12-31 | $4.00M 6-K · filed 2024-02-02 | |
| 2022-06-30 | $4.47M 6-K · filed 2023-02-28 | |
| 2021-12-31 | $1.47M 20-F · filed 2023-04-18 | |
| 2021-09-30 | $1.62M 6-K · filed 2021-12-30 | |
| 2021-06-30 | $578.00K 6-K · filed 2021-09-10 | |
| 2021-03-31 | $673.00K 6-K · filed 2021-06-16 | |
| 2020-12-31 | $1.36M 20-F · filed 2022-04-14 | |
| 2020-09-30 | $1.55M 6-K · filed 2020-11-17 | |
| 2020-06-30 | $1.75M 6-K · filed 2020-09-03 | |
| 2020-03-31 | $1.89M 6-K · filed 2020-06-11 | |
| 2019-12-31 | $1.94M 20-F · filed 2021-04-30 | |
| 2019-09-30 | $2.09M 6-K · filed 2019-12-18 | |
| 2019-06-30 | $2.26M 6-K · filed 2019-09-18 | |
| 2019-03-31 | $2.43M 6-K · filed 2019-07-10 | |
| 2019-01-01 | $2.56M 20-F · filed 2020-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |